| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |